Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2017.10.007
Abstract: OBJECTIVES The objective of this study was to determine the overall tolerability and toxicity of olaparib capsules among older (≥65years) patients with recurrent ovarian cancer treated on 8 completed prospective trials of olaparib. METHODS An… read more here.
Keywords: olaparib capsules; age; toxicity; ovarian cancer ... See more keywords